Results 341 to 350 of about 348,390 (367)

mTOR dysregulation and tuberous sclerosis-related epilepsy

Expert Review of Neurotherapeutics, 2018
P. Curatolo, R. Moavero, J. van Scheppingen, E. Aronica   +3 more
semanticscholar   +1 more source

Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism

Cell, 2020
Verian Bader, Stefanie Haase, Johannes Kaisler   +2 more
exaly  

Tuberous Sclerosis

Archives of Neurology, 1970
R. H. Wilkins, I. A. Brody
openaire   +2 more sources

Tuberous sclerosis

Journal of the American Podiatric Medical Association, 1983
D W, Hugar, R W, Rozelle
openaire   +2 more sources

Remyelination therapies: a new direction and challenge in multiple sclerosis

Nature Reviews Drug Discovery, 2017
Jason R Plemel, V Wee Yong
exaly  

Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations.

European journal of paediatric neurology, 2018
P. Curatolo, R. Nabbout, L. Lagae, E. Aronica, J. Ferreira, M. Feucht, C. Hertzberg, A. Jansen, F. Jansen, K. Kotulska, R. Moavero, F. O'callaghan, A. Papavasiliou, M. Tzadok, S. Jóźwiak   +14 more
semanticscholar   +1 more source

Immunopathology of multiple sclerosis

Nature Reviews Immunology, 2015
Calliope A Dendrou, Lars Fugger, Manuel A Friese   +2 more
exaly  

Dynamics of oligodendrocyte generation in multiple sclerosis

Nature, 2019
Mehdi Djelloul, Samuel Bernard, Mehran Salehpour   +2 more
exaly  

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

Nature, 2012
Gereon Poschmann, Calliope A Dendrou, Kathrine E Attfield   +2 more
exaly  

Imaging of Tuberous Sclerosis

American Journal of Roentgenology, 2016
S. Tresoldi, F. Sardanelli
openaire   +4 more sources